Management of epithelial ovarian neoplasms using a platinum-based regimen: A 10-year experience
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (1) , 66-73
- https://doi.org/10.1016/0090-8258(90)90310-h
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Is routine second-look laparotomy for ovarian cancer justified?Gynecologic Oncology, 1988
- Treatment of advanced ovarian cancer with sequential combination chemotherapyCancer, 1987
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group studyCancer, 1986
- Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatinCancer, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinomaCancer, 1983
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- Chemotherapy in the treatment of cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1970